Warburg micro syndrome is an autosomal recessive disease where patients present with optic, neurologic and genital symptoms. Until now, four disease genes for Warburg micro syndrome, RAB3GAP1, RAB3GAP2, RAB18 and TBC1D20, have been identified. Here, we report two novel homozygous RAB3GAP1 mutations (c.22G>T, p.Glu8* and c.1353delA, p.Pro452Hisfs*5) in two consanguineous families by whole-exome sequencing.
Warburg micro syndrome (WARBM) is a rare, genetically heterogeneous, autosomal recessive syndrome. Patients with WARBM present with severe mental retardation, brain anomalies (polymicrogyria and corpus callosum hypoplasia), craniofacial features (microcephaly, hairy forehead, large anteverted ear, broad nasal root and micrognathia), ocular defects (congenital cataract, microphthalmia and microcornea), spasticity leading to contracture, congenital hypotonia and hypogonadism.1,
Patient II-1 in family 1 (patient 1) is a 4-year-old Iranian girl born to consanguineous parents. She was born at 33 weeks of gestation after premature rupture of membranes without asphyxia (Apgar scores were 9 and 10 at 1 and 5 min, respectively). Her birth weight, length and head circumference were 1,850 g (7th centile), 49 cm (<5th centile) and 31 cm (7th centile), respectively. At birth, she showed characteristic craniofacial features (microcephaly, bitemporal narrowing, soft cleft palate, small mouth, micrognathia and large ears), ocular symptoms (bilateral cataract, microphthalmia and microcornea) and pectus carinatum. At 1 year of age, severe mental retardation, cerebral palsy, axial hypotonia and peripheral spasticity were recognized, with no seizures. At 17 months, a brain FLAIR-image revealed dysmyelination of the white matter implying severe hypoxic-ischemic encephalopathy, and the dysgenesis of corpus callosum. At 19 months, she showed mild bilateral conductive hearing loss detected by auditory brainstem response test. Currently at 4 years, she cannot sit independently. Neither parents have hearing impairments, pectus carinatum or soft cleft palates. Chromosome analysis of the patient was normal.
Patient II-3 in family 2 (patient 2) is an Indian girl, who is the third child of two healthy first cousins (Figure 1a). She had two unaffected siblings. She was born at 38 weeks of gestation by repeat cesarean section after an uneventful pregnancy. Her birth weight was 2,000 g (<5th centile). At 16 months of age, her weight was 6.2 kg (<5th centile), length 72 cm (<5th centile) and head circumference was 40 cm (<5th centile). She showed severe mental retardation, spoke only ‘mama’, ‘papa’ and ‘dada’ with hypotonia, exaggerated deep tendon reflexes in both legs, and hearing impairment. She had trigonocephaly, bilateral low-set prominent ears with anteriorly angulated, broad nasal root, micrognathia and a high-arched palate, and bilateral proximal placement of the thumbs and fifth toes. Microphthalmia, unresponsive pupils, microcornea and bilateral cataracts with very small vitreous cavities, leading to complete blindness were also noted. Hematological examination, thyroid, liver and renal function, serum calcium, ammonia, lactate, pyruvate and TORCH (toxoplasmosis, rubella, cytomegalovirus and herpes virus) were all normal at 16 months of age. Echocardiography, abdominal ultrasonography and skeletal survey were all normal, chromosomes were normal, and no hearing impairments were present in other family members.
The affected individuals from families 1 and 2 and their parents were analyzed. Peripheral blood samples were collected after obtaining written informed consent. DNA was extracted from peripheral blood leukocytes using the QIAamp DNA mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The Institutional Review Board of Yokohama City University School of Medicine approved this study.
Whole-exome sequencing was performed for the two affected individuals (II-1 in family 1, and II-3 in family 2) and for the unaffected parents of family 2 as previously reported.11,12 Briefly, genomic DNA (3 μg per sample) extracted from peripheral blood was sheared to 200 bp fragments using a Covaris S2 system (Covaris, Woburn, MA, USA). Genome partitioning was performed using a SureSelect Human All Exon Kit v5 (Agilent Technologies, Santa Clara, CA, USA). The prepared libraries were sequenced on a HiSeq2000 (Illumina, San Diego, CA, USA) with 101 bp paired-end reads with 7 bp index reads. Both reads were aligned to the human reference genome hg19 by Novoalign 3.00 (http://www.novocraft.com). The aligned reads were processed using Picard to remove polymerase chain reaction (PCR) duplicates (http://picard.sourceforge.net). The variants were called using the Genome Analysis Toolkit 2.4–4 (GATK; http://www.broadinstitute.org/gatk) with the GATK Best Practice Variant Detection v3 recommendations (http://www.broadinstitute.org/gatk/guide/topic?name=best-practices) and annotated using ANNOVAR (8 March 2012; http://www.openbioinformatics.org/annovar). Using these criteria, only variants located in the coding region and the adjacent 2 bp were identified. Common variants registered in dbSNP build 137 (minor allele frequency⩾0.01; http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=316787363&g=snp137Common&hgTracksConfigPage=configure) were excluded. On the basis of the consanguinity in both families where autosomal recessive inheritance was considered, and homozygous variants were focused and validated by Sanger method (Supplementary Tables 1 and 2). PCR products were sequenced on an ABI3500xL sequencer (Applied Biosystems, Foster City, CA, USA) and analyzed using Sequencher 5.0 (Gene Codes Corporation, Ann Arbor, MI, USA).
The average-read depths for RefSeq coding DNA sequences were 88.5–99.1x in whole-exome sequencing. After in silico analysis, we focused on 16 and 13 homozygous candidate variants in patient 1 and patient 2, respectively (Supplementary Tables 3 and 4). Among these variants, homozygous truncating mutations were identified in RAB3GAP1 (NM_001143905): c.22G>T (p.Glu8*) in patient 1, and c.1353delA (p.Pro452Hisfs*5) in patient 2. Both mutations are novel. Each parents had a heterozygous mutation (Figure 1b). These mutations were absent in the NHLBI Exome Sequencing Project, the 1000 Genomes database and in our in-house exome database (n=575).
The RAB3GAP1 gene encodes RAB3 GTPase-activating protein, which has a role in converting the active GTP-bound form to the inactive GDP-bound form of RAB3 proteins, which in turn regulate hormone and neurotransmitter exocytosis.13,14 Among the four genes involved, RAB3GAP1 mutations are present in ~40% of WARBM patients, making it the most frequent cause. More than 50 mutations in RAB3GAP1 have been reported to date in the Human Genome Mutation Database (https://portal.biobase-international.com). Interestingly, they are mostly truncating mutations (nonsense, frameshift and splice-site) or microdeletions.5,6,9
Here we report two novel truncating RAB3GAP1 mutations (c.22G>T, p.Glu8* and c.1353delA, p.Pro452Hisfs*5) in two independent families. Both patients showed typical features of WARBM (Table 1). Of note, hearing impairment has been reported only in one patient,6 but was recognized in both patients described here, though we could not find any mutations that would cause hearing loss. Pectus carinatum and soft cleft palate, found in patient 1, have never been reported (Supplementary Table 5). As WARBM patients show variable skeletal abnormalities like pectus excavatum, kyphoscoliosis, hip dislocation and limb anomalies, pectus carinatum appears to be one of the skeletal phenotypes in WARBM.
In conclusion, we report two WARBM patients with novel RAB3GAP1 mutations. The hearing impairment, pectus carinatum and soft cleft palates seen in these patients have rarely or never been noted in WARBM.
Miyake, Noriko, & Matsumoto, Naomichi HGV Database http://dx.doi.org/10.6084/m9.figshare.hgv.699 (2015)
We thank the patients and their families for participating in this study. We also thank Ms. S Sugimoto and K Takabe for their technical assistance. This work was supported by grants from the Ministry of Health, Labour and Welfare (H Saitsu, N Miyake and N Matsumoto), a Grant-in-Aid for Scientific Research (A) (NM), a Grant-in-Aid for Scientific Research (B) (HS and NMi), a Grant-in-Aid for Scientific Research (C) (SM), a Grant-in-Aid for challenging Exploratory Research (HS) from the Japan Society for the Promotion of Science, the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency (NMa), a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (NMi and NMa), and the Takeda Science Foundation (Hs, NMi and NMa) and the Strategic Research Program for Brain Science (SRPBS) from Japan Agency for Medical Research and Development (AMED) (NMa).